Reuters reports that fiscally-troubled Olympus be rescued by a competitor: Sony.
Fujifilm Holdings is also a reported potential investor, although it might face more regulatory issues than Sony. Both companies are apparently more interested in Olympus’ medical equipment business than its cameras’ Fujifilm already holds about a 10 percent share of the diagnostic endoscope market.
“Sony, which has relatively little experience in the healthcare sector, supplies image sensors to Olympus and is considered keen to tap into its lucrative business in diagnostic endoscopes, where it holds a 70 percent global market share,” Reuters says.
Olympus executives over many years hid $1.7 billion in accounting losses; the company recently announced it is suing 19 former execs.
________________________________________________
Recent Comments